Cargando…

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial

BACKGROUND: Soft-tissue sarcomas (STS) represent a heterogeneous group of rare tumors including more than 70 different histological subtypes. High throughput molecular analysis (next generation sequencing exome [NGS]) is a unique opportunity to identify driver mutations that can change the usual one...

Descripción completa

Detalles Bibliográficos
Autores principales:	Italiano, Antoine, Dinart, Derek, Soubeyran, Isabelle, Bellera, Carine, Espérou, Hélène, Delmas, Christelle, Mercier, Noémie, Albert, Sabrina, Poignie, Ludivine, Boland, Anne, Bourdon, Aurélien, Geneste, Damien, Cavaille, Quentin, Laizet, Yec’han, Khalifa, Emmanuel, Auzanneau, Céline, Squiban, Barbara, Truffaux, Nathalène, Olaso, Robert, Gerber, Zuzana, Wallet, Cédrick, Bénard, Antoine, Blay, Jean-Yves, Laurent-Puig, Pierre, Deleuze, Jean-François, Lucchesi, Carlo, Mathoulin-Pelissier, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570026/ https://www.ncbi.nlm.nih.gov/pubmed/34740331 http://dx.doi.org/10.1186/s12885-021-08878-2

Ejemplares similares

Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan
por: Auzanneau, Céline, et al.
Publicado: (2020)

Inactivating mutations in genes encoding for components of the BAF/PBAF complex and immune-checkpoint inhibitor outcome
por: Courtet, Kevin, et al.
Publicado: (2020)

Clinical impact of extensive molecular profiling in advanced cancer patients
por: Cousin, Sophie, et al.
Publicado: (2017)

Targeting ERBB2 mutations in solid tumors: biological and clinical implications
por: Cousin, Sophie, et al.
Publicado: (2018)

Suivi de la réponse sérologique au virus SARS-CoV-2 chez des professionnels de santé d'un centre de lutte contre le cancer dans un contexte de pandémie de COVID19 (PRO-SERO-COV)
por: Cantarel, C., et al.
Publicado: (2022)

Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
por: Toulmonde, Maud, et al.
Publicado: (2023)

Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial
por: Soubeyran, Pierre, et al.
Publicado: (2016)

Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency Ablation
por: Miles, James, et al.
Publicado: (2022)

PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials
por: Italiano, Antoine, et al.
Publicado: (2020)

Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas
por: Crombé, Amandine, et al.
Publicado: (2022)

One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score
por: Bourdel-Marchasson, Isabelle, et al.
Publicado: (2016)

Draft Genome Sequence of the Starmerella bacillaris (syn., Candida zemplinina) Type Strain CBS 9494
por: Rosa, Alberto Luis, et al.
Publicado: (2018)

Correction for Rosa et al., “Draft Genome Sequence of the Candida zemplinina (syn., Starmerella bacillaris) Type Strain CBS 9494”
por: Rosa, Alberto Luis, et al.
Publicado: (2018)

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas
por: Blanchi, Julie, et al.
Publicado: (2023)

PRognostic factor of Early Death In phase II Trials or the end of ‘sufficient life expectancy’ as an inclusion criterion? (PREDIT model)
por: Grellety, Thomas, et al.
Publicado: (2016)

Optimal biological dose: a systematic review in cancer phase I clinical trials
por: Fraisse, J., et al.
Publicado: (2021)

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
por: Bellera, Carine A, et al.
Publicado: (2010)

Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study
por: Soubeyran, Pierre, et al.
Publicado: (2014)

Surrogate endpoints in advanced sarcoma trials: a meta-analysis
por: Savina, Marion, et al.
Publicado: (2018)

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer
por: Cousin, Sophie, et al.
Publicado: (2022)

Epithelial atypia in biopsies performed for microcalcifications. Practical considerations about 2,833 serially sectioned surgical biopsies with a long follow-up
por: de Mascarel, Isabelle, et al.
Publicado: (2007)

Factors influencing general practitioners in the referral of elderly cancer patients
por: Delva, Fleur, et al.
Publicado: (2011)

Deep learning predicts patients outcome and mutations from digitized histology slides in gastrointestinal stromal tumor
por: Fu, Yu, et al.
Publicado: (2023)

Dealing with paralogy in RADseq data: in silico detection and single nucleotide polymorphism validation in Robinia pseudoacacia L.
por: Verdu, Cindy F., et al.
Publicado: (2016)

Breast cancer care compared with clinical Guidelines: an observational study in France
por: Lebeau, Marie, et al.
Publicado: (2011)

One-Year Follow-Up of Seroprevalence of SARS-CoV-2 Infection and Anxiety among Health Workers of a French Cancer Center: The PRO-SERO-COV Study
por: Richez, Brice, et al.
Publicado: (2023)

Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
por: Toulmonde, Maud, et al.
Publicado: (2022)

Impact of the coronavirus disease 2019 pandemic on sarcoma management in France: a 2019 and 2020 comparison
por: Penel, Nicolas, et al.
Publicado: (2023)

Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial
por: Palussière, J., et al.
Publicado: (2018)

Systemic chemotherapy plus cetuximab after complete surgery in the treatment of isolated colorectal peritoneal carcinoma: COCHISE phase II clinical trial
por: Evrard, Serge, et al.
Publicado: (2019)

GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials
por: Dinart, D., et al.
Publicado: (2020)

Survival outcomes of patients with metastatic non-small cell lung cancer receiving chemotherapy or immunotherapy as first-line in a real-life setting
por: Belaroussi, Yaniss, et al.
Publicado: (2023)

Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma
por: Morvan, Valérie Le, et al.
Publicado: (2020)

OSIRIS: A Minimum Data Set for Data Sharing and Interoperability in Oncology
por: Guérin, Julien, et al.
Publicado: (2021)

Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts
por: Oubaya, Nadia, et al.
Publicado: (2021)

Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
por: Dromer, Françoise, et al.
Publicado: (2007)

Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study
por: Villa, Antoine, et al.
Publicado: (2019)

Perspectives on cancer care in older patients in France
por: Hauchecorne, Mathilde, et al.
Publicado: (2020)

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case–control study—study protocol
por: Lacourt, Aude, et al.
Publicado: (2019)

Targeting epigenetics in sarcomas through EZH2 inhibition
por: Italiano, Antoine
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3j1s781mtesi08hin6nd31q7lb